Primary Record
peruvoside
- In stock
- 7,689 g
- Purity
- 99.2 %
- CAS
- 1182-87-2
Compound Identifiers & Properties
- CAS
- 1182-87-2
- PubChem CID
- 12314120
- SMILES
- C[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C=O)O)OC)O
- Canonical SMILES
- CO[C@H]1[C@H](O)[C@H](O[C@H]2CC[C@@]3(C=O)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)O[C@@H](C)[C@@H]1O
Names & Synonyms
- peruvoside
- Encordin
- Peruvosid
- Cannogenin thevetoside
- Pervoside
- Enordin
- 1182-87-2
- Cannogenin alpha-L-thevetoside
- CT36KGC6A6
- PERUVOSIDE [MI]
- UNII-CT36KGC6A6
- RefChem:171875
- Cannogenin ?-L-thevetoside
- PERUVOSIDE [WHO-DD]
- Cannogenin |A-L-Thevetoside
- Cannogenin .alpha.-l-thevetoside
- SCHEMBL700735
- DTXSID70881388
- orb1990657
- C30H44O9
- CHEMBL1075790
- EINECS 214-659-9
- CHEBI:135825
- DTXCID501022650
- MFCD00133752
- Bicyclo[4.3.0]nona-3,6(1)-diene
- C30-H44-O9
- DB13756
- J7.302D
- CID:12314120
- FD146105
- SID:134222069
- HY-108016
- CS-0027154
- E88664
- C100098
- (3S,5R,8R,9S,10R,13R,14S,17R)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
- Q7171218
- 3-((6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy)-14-hydroxy-19-oxo-card-20(22)-enolide
- (3S,5R,8R,9S,10R,13R,14S,17R)-3-[(2S,3R,4S,5R,6R)-3,5-Dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
- Card-20(22)-enolide, 3-((6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy)-14-hydroxy-19-oxo-, (3beta,5beta)-
- 3 beta,14 beta-dihydroxy-19-oxo-5 beta-card-20(22)-enolide-3 alpha-L-thevetoside
- (1R,3aS,3bR,5aR,7S,9aR,9bS,11aR)-7-{[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-11a-methyl-1-(5-oxo-2,5-dihydrofuran-3-yl)-hexadecahydro-1H-cyclopenta[a]phenanthrene-9a-carbaldehyde
- (3|A,5|A)-3-[(6-Deoxy-3-O-methyl-|A-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
- (3b,5b)-3-[(6-Deoxy-3-O-methyl-a-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
- (3beta,5beta)-3-((6-Deoxy-3-O-methyl-alpha-L -glucopyranosyl)oxy)-14-hydroxy-19-oxocard-20(22)-enolide
- (3beta,5beta)-3-[(6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
- (3S,5R,8R,9S,10R,13R,14S,17R)-3-((2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta(a)phenanthrene-10-carbaldehyde
- (3S,5R,8R,9S,10R,13R,14S,17R)-3-((2S,3R,4S,5S,6R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta(a)phenanthrene-10-carbaldehyde
- (3S,5R,8R,9S,10R,13R,14S,17R)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
- 214-659-9
- 3beta-[(6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-5beta,14beta-card-20(22)-enolide
- 3beta-[(6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-5beta-card-20(22)-enolide
- CARD-20(22)-ENOLIDE, 3-((6-DEOXY-3-O-METHYL-.ALPHA.-L-GLUCOPYRANOSYL)OXY)-14-HYDROXY-19-OXO-, (3.BETA.,5.BETA.)-
- Card-20(22)-enolide, 3-((6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy)-14-hydroxy-19-oxo-, (3-beta,5-beta)-
- Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.alpha.-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-, (3.beta.,5.beta.)-